Bruker (BRKR) FCF Payout Ratio (QoQ) (2016 - 2026)
Analysis
Bruker (BRKR) FCF Payout Ratio (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -143.67% |
| Mar 31, 2026 | 120.43% |
| Dec 31, 2025 | 152.22% |
| Sep 30, 2025 | -175.05% |
| Jun 30, 2025 | -125.87% |
| Mar 31, 2025 | 298.25% |
| Dec 31, 2024 | -96.22% |
| Sep 30, 2024 | 499.91% |
| Jun 30, 2024 | -101.80% |
| Mar 31, 2024 | 43,400.00% |
| Dec 31, 2023 | -90.25% |
| Sep 30, 2023 | 1,605.81% |
| Jun 30, 2023 | -124.13% |
| Mar 31, 2023 | 119.04% |
| Dec 31, 2022 | -91.38% |
| Sep 30, 2022 | 620.93% |
| Jun 30, 2022 | -194.38% |
| Mar 31, 2022 | 134.27% |
| Dec 31, 2021 | -93.22% |
| Sep 30, 2021 | 109.36% |